Titan Medical Launches “Titan Living Labs” Showcasing a Behind-the-Scenes Look at Product Development
February 16 2021 - 7:00AM
Business Wire
Titan Medical Inc. (“Titan” or the “Company”)
(TSX: TMD) (Nasdaq: TMDI), a medical
device company focused on the design and development of surgical
technologies for robotic single access surgery, today announced the
launch of “Titan Living Labs”, a new media-rich addition to its
website providing access to the stories behind the design,
engineering and innovative technologies employed by Titan’s
engineering team for the Enos™ robotic single access surgical
system.
“The heart of Titan is its intellectual capital including its
engineering team, which is focused on solving the challenges of
robotic surgery. With Titan Living Labs, we are excited to present
stories in video, text and photography on how Titan team members
approach, solve and advance aspects of robotic assisted surgery,”
said David McNally, President and Chief Executive Officer of Titan.
“With this initiative, we hope to share our advancements on a range
of topics such as handpiece and instruments design, to anecdotes on
the role of physics, points of inspiration for our innovations, and
how surgeon feedback influences fundamental engineering
choices.”
Titan Living Labs is accessible via the Company’s website at
www.titanmedicalinc.com.
About Titan Medical
Titan Medical Inc., a medical device company headquartered in
Toronto, is focused on developing robotic assisted technologies for
application in single access surgery. The Enos system, by Titan
Medical, is being developed with dual 3D and 2D high-definition
vision systems, multi-articulating instruments, and an ergonomic
surgeon workstation. With the Enos system, Titan intends to
initially pursue gynecologic surgical indications.
Certain of Titan’s robotic assisted surgical technologies and
related intellectual property have been licensed to Medtronic plc,
while retaining world-wide rights to commercialize the technologies
for use with the Enos system.
Enos™ is a trademark of Titan Medical Inc.
For more information, please visit www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking statements” within
the meaning of applicable Canadian and U.S. securities laws. Such
statements reflect the current expectations of management of the
Company’s future growth, results of operations, performance and
business prospects and opportunities. Wherever possible, words such
as “may”, “would”, “could”, “will”, “anticipate”, “believe”,
“plan”, “expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements, including, without limitation, references to: the
Company’s focus on the design and development of surgical
technologies for robotic single access surgery, the Company’s hope
to share its advancements on a range of topics through the Titan
Living Labs addition to its website, that the Enos system is being
developed with dual 3D and 2D high-definition vision systems,
multi-articulating instruments and an ergonomic surgeon workstation
and that Titan intends to initially pursue gynecologic surgical
indications. These statements reflect management’s current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Report on Form 20-F for the fiscal year ended December 31, 2019
(which may be viewed at www.sedar.com and at www.sec.gov). Should
one or more of these risks or uncertainties materialize, or should
assumptions underlying the forward-looking statements prove
incorrect, actual results, performance, or achievements may vary
materially from those expressed or implied by the forward-looking
statements contained in this news release. These factors should be
considered carefully, and prospective investors should not place
undue reliance on the forward-looking statements. Although the
forward-looking statements contained in the news release are based
upon what management currently believes to be reasonable
assumptions, the Company cannot assure prospective investors that
actual results, performance or achievements will be consistent with
these forward-looking statements. Except as required by law, the
Company expressly disclaims any intention or obligation to update
or revise any forward-looking statements whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210216005483/en/
Monique L. Delorme Chief Financial Officer +1-416-548-7522
investors@titanmedicalinc.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Sep 2023 to Sep 2024